Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fertilization in Vitro | 63 | 2024 | 1292 | 7.160 |
Why?
|
Embryo Transfer | 39 | 2023 | 522 | 4.170 |
Why?
|
Preimplantation Diagnosis | 9 | 2023 | 143 | 3.600 |
Why?
|
Infertility | 18 | 2024 | 654 | 3.460 |
Why?
|
Infertility, Female | 25 | 2024 | 760 | 3.200 |
Why?
|
Oocytes | 26 | 2023 | 1166 | 3.060 |
Why?
|
Reproductive Techniques, Assisted | 17 | 2024 | 496 | 2.930 |
Why?
|
Cryopreservation | 20 | 2023 | 728 | 2.840 |
Why?
|
Public Opinion | 9 | 2019 | 484 | 2.710 |
Why?
|
Pregnancy Rate | 34 | 2023 | 648 | 2.490 |
Why?
|
Oocyte Retrieval | 13 | 2022 | 160 | 2.430 |
Why?
|
Ovulation Induction | 14 | 2023 | 277 | 2.390 |
Why?
|
Live Birth | 13 | 2024 | 510 | 2.240 |
Why?
|
Oocyte Donation | 6 | 2024 | 52 | 2.220 |
Why?
|
Chorionic Gonadotropin | 10 | 2019 | 457 | 2.140 |
Why?
|
Fertility | 12 | 2023 | 769 | 1.860 |
Why?
|
Aneuploidy | 10 | 2023 | 552 | 1.860 |
Why?
|
Abortion, Spontaneous | 12 | 2023 | 532 | 1.810 |
Why?
|
Sperm Injections, Intracytoplasmic | 9 | 2023 | 156 | 1.600 |
Why?
|
Pregnancy | 89 | 2024 | 29868 | 1.450 |
Why?
|
Ovary | 11 | 2020 | 959 | 1.390 |
Why?
|
Pregnancy Outcome | 19 | 2024 | 2921 | 1.240 |
Why?
|
Estradiol | 23 | 2014 | 1937 | 1.240 |
Why?
|
Pregnancy, Ectopic | 6 | 2017 | 142 | 1.190 |
Why?
|
Genetic Testing | 9 | 2023 | 3533 | 1.170 |
Why?
|
Hysteroscopy | 5 | 2024 | 62 | 1.170 |
Why?
|
Embryo, Mammalian | 11 | 2022 | 1670 | 1.150 |
Why?
|
Reproductive Medicine | 3 | 2020 | 99 | 1.150 |
Why?
|
Leuprolide | 4 | 2023 | 312 | 1.140 |
Why?
|
Blastocyst | 9 | 2023 | 432 | 1.110 |
Why?
|
Uterine Diseases | 2 | 2024 | 108 | 1.080 |
Why?
|
Ovarian Hyperstimulation Syndrome | 3 | 2020 | 47 | 1.040 |
Why?
|
Progesterone | 12 | 2018 | 742 | 1.020 |
Why?
|
Gonadotropins | 4 | 2020 | 241 | 1.000 |
Why?
|
Maternal Age | 8 | 2019 | 809 | 0.990 |
Why?
|
Follicle Stimulating Hormone, Human | 2 | 2020 | 25 | 0.970 |
Why?
|
Gynatresia | 1 | 2024 | 11 | 0.930 |
Why?
|
Tissue Preservation | 2 | 2016 | 174 | 0.850 |
Why?
|
Single Embryo Transfer | 2 | 2019 | 29 | 0.800 |
Why?
|
Birth Rate | 4 | 2023 | 168 | 0.780 |
Why?
|
Paternal Age | 1 | 2021 | 87 | 0.740 |
Why?
|
Obesity | 12 | 2023 | 12933 | 0.740 |
Why?
|
Contraceptive Devices, Female | 2 | 2018 | 40 | 0.740 |
Why?
|
Female | 166 | 2024 | 392148 | 0.740 |
Why?
|
Embryo Implantation | 10 | 2023 | 270 | 0.730 |
Why?
|
Luteal Phase | 3 | 2018 | 138 | 0.720 |
Why?
|
Ovarian Follicle | 7 | 2022 | 244 | 0.710 |
Why?
|
Anti-Mullerian Hormone | 5 | 2021 | 407 | 0.680 |
Why?
|
Follicle Stimulating Hormone | 6 | 2012 | 726 | 0.670 |
Why?
|
Surrogate Mothers | 2 | 2018 | 16 | 0.670 |
Why?
|
Personal Autonomy | 2 | 2018 | 304 | 0.650 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2019 | 4007 | 0.640 |
Why?
|
Adult | 111 | 2024 | 220969 | 0.640 |
Why?
|
Pregnancy, Multiple | 6 | 2023 | 215 | 0.620 |
Why?
|
Uterine Hemorrhage | 4 | 2023 | 240 | 0.610 |
Why?
|
Directed Tissue Donation | 1 | 2017 | 18 | 0.570 |
Why?
|
Infant, Small for Gestational Age | 1 | 2020 | 462 | 0.570 |
Why?
|
Insemination, Artificial | 4 | 2011 | 99 | 0.560 |
Why?
|
Intrauterine Devices, Medicated | 1 | 2017 | 26 | 0.560 |
Why?
|
Levonorgestrel | 1 | 2017 | 74 | 0.550 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2017 | 81 | 0.550 |
Why?
|
Compensation and Redress | 1 | 2017 | 66 | 0.550 |
Why?
|
Humans | 170 | 2024 | 760617 | 0.530 |
Why?
|
Breast Neoplasms | 20 | 2022 | 20988 | 0.520 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2020 | 376 | 0.520 |
Why?
|
Transsexualism | 1 | 2019 | 208 | 0.510 |
Why?
|
Endometrial Neoplasms | 2 | 2018 | 1365 | 0.510 |
Why?
|
Menstruation Disturbances | 1 | 2016 | 143 | 0.500 |
Why?
|
Tissue Donors | 6 | 2024 | 2331 | 0.500 |
Why?
|
Endocrinology | 2 | 2013 | 442 | 0.490 |
Why?
|
Carcinoma, Endometrioid | 1 | 2018 | 276 | 0.490 |
Why?
|
Gastroplasty | 1 | 2016 | 157 | 0.480 |
Why?
|
Premenopause | 6 | 2012 | 1038 | 0.470 |
Why?
|
Neoplasms | 9 | 2024 | 22131 | 0.470 |
Why?
|
Ideal Body Weight | 1 | 2014 | 27 | 0.460 |
Why?
|
Retrospective Studies | 46 | 2024 | 80566 | 0.460 |
Why?
|
Antineoplastic Agents, Hormonal | 3 | 2011 | 1520 | 0.450 |
Why?
|
Hysterectomy | 3 | 2018 | 856 | 0.440 |
Why?
|
Uterus | 5 | 2018 | 649 | 0.440 |
Why?
|
Insemination, Artificial, Homologous | 1 | 2013 | 17 | 0.440 |
Why?
|
Young Adult | 29 | 2023 | 59179 | 0.440 |
Why?
|
Posthumous Conception | 1 | 2012 | 11 | 0.420 |
Why?
|
Survivors | 6 | 2014 | 2372 | 0.410 |
Why?
|
Recombinant Proteins | 4 | 2020 | 6520 | 0.410 |
Why?
|
Semen | 4 | 2023 | 347 | 0.410 |
Why?
|
Estrogen Replacement Therapy | 7 | 1999 | 1208 | 0.400 |
Why?
|
Preconception Care | 3 | 2019 | 141 | 0.390 |
Why?
|
Ultrasonography, Prenatal | 5 | 2018 | 1754 | 0.380 |
Why?
|
Methotrexate | 2 | 2017 | 1716 | 0.370 |
Why?
|
Postmenopause | 8 | 2000 | 2511 | 0.360 |
Why?
|
Prolactin | 6 | 2020 | 625 | 0.350 |
Why?
|
Adolescent | 29 | 2024 | 88234 | 0.340 |
Why?
|
Multiple Birth Offspring | 1 | 2009 | 22 | 0.330 |
Why?
|
Bariatric Surgery | 2 | 2010 | 992 | 0.330 |
Why?
|
Myometrium | 2 | 2004 | 174 | 0.320 |
Why?
|
Counseling | 3 | 2024 | 1538 | 0.310 |
Why?
|
Amenorrhea | 4 | 2021 | 483 | 0.310 |
Why?
|
Tamoxifen | 2 | 2011 | 965 | 0.300 |
Why?
|
Gastric Bypass | 1 | 2016 | 818 | 0.300 |
Why?
|
Primary Ovarian Insufficiency | 2 | 2023 | 107 | 0.300 |
Why?
|
Spermatozoa | 4 | 2024 | 629 | 0.290 |
Why?
|
Patient Selection | 2 | 2019 | 4237 | 0.290 |
Why?
|
Vaginal Creams, Foams, and Jellies | 3 | 2018 | 62 | 0.290 |
Why?
|
Body Mass Index | 11 | 2023 | 12943 | 0.290 |
Why?
|
Attitude | 1 | 2012 | 772 | 0.280 |
Why?
|
Insurance Coverage | 1 | 2018 | 1937 | 0.280 |
Why?
|
Obesity, Morbid | 1 | 2018 | 1276 | 0.280 |
Why?
|
Estrone | 3 | 1998 | 234 | 0.280 |
Why?
|
Receptors, LHRH | 1 | 2007 | 158 | 0.270 |
Why?
|
Embryo Culture Techniques | 3 | 2021 | 84 | 0.270 |
Why?
|
Antineoplastic Agents | 8 | 2023 | 13635 | 0.270 |
Why?
|
Alkylating Agents | 2 | 2023 | 133 | 0.270 |
Why?
|
Tissue Adhesions | 2 | 2024 | 218 | 0.260 |
Why?
|
Fertility Agents, Female | 5 | 2011 | 101 | 0.260 |
Why?
|
Mammary Glands, Animal | 5 | 2009 | 272 | 0.260 |
Why?
|
Reproduction | 2 | 2012 | 645 | 0.250 |
Why?
|
Potassium Chloride | 2 | 2004 | 229 | 0.250 |
Why?
|
Pregnancy Trimester, First | 3 | 2018 | 908 | 0.250 |
Why?
|
Ethanol | 3 | 1996 | 1320 | 0.240 |
Why?
|
Germ Cells | 3 | 2024 | 634 | 0.240 |
Why?
|
Pregnancy, Tubal | 1 | 2004 | 15 | 0.240 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3194 | 0.240 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 2009 | 1148 | 0.230 |
Why?
|
Male | 44 | 2024 | 360358 | 0.230 |
Why?
|
Linear Models | 4 | 2019 | 5866 | 0.230 |
Why?
|
Electrocoagulation | 1 | 2004 | 152 | 0.220 |
Why?
|
Chorion | 2 | 2018 | 114 | 0.220 |
Why?
|
Age Factors | 11 | 2021 | 18381 | 0.220 |
Why?
|
Trophoblasts | 1 | 2005 | 224 | 0.220 |
Why?
|
Ploidies | 2 | 2021 | 285 | 0.210 |
Why?
|
Health Services Accessibility | 2 | 2018 | 5430 | 0.210 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3351 | 0.210 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5672 | 0.210 |
Why?
|
Oogenesis | 1 | 2022 | 124 | 0.200 |
Why?
|
Menopause | 3 | 2008 | 1645 | 0.200 |
Why?
|
Cross-Sectional Studies | 9 | 2024 | 26049 | 0.200 |
Why?
|
Reproductive Techniques | 1 | 2001 | 41 | 0.190 |
Why?
|
Alcohol Drinking | 5 | 2012 | 4025 | 0.190 |
Why?
|
Gamete Intrafallopian Transfer | 1 | 2001 | 27 | 0.190 |
Why?
|
Metacarpus | 1 | 2001 | 36 | 0.190 |
Why?
|
Insemination | 1 | 2021 | 18 | 0.190 |
Why?
|
Middle Aged | 34 | 2024 | 220584 | 0.190 |
Why?
|
Education, Medical | 1 | 2013 | 1724 | 0.190 |
Why?
|
Menstruation | 2 | 2017 | 306 | 0.190 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2017 | 3612 | 0.190 |
Why?
|
Insurance | 1 | 2022 | 113 | 0.180 |
Why?
|
Sterilization Reversal | 1 | 2020 | 2 | 0.180 |
Why?
|
Nitrogen Mustard Compounds | 1 | 2020 | 44 | 0.180 |
Why?
|
Fertilization | 3 | 2010 | 198 | 0.170 |
Why?
|
Erectile Dysfunction | 1 | 2023 | 444 | 0.170 |
Why?
|
Chromosome Segregation | 1 | 2001 | 234 | 0.170 |
Why?
|
Sterilization, Tubal | 1 | 2020 | 75 | 0.170 |
Why?
|
Treatment Outcome | 17 | 2022 | 64568 | 0.170 |
Why?
|
Th2 Cells | 1 | 2005 | 1056 | 0.170 |
Why?
|
Zygote | 1 | 2000 | 115 | 0.170 |
Why?
|
Infant, Newborn | 9 | 2023 | 26180 | 0.170 |
Why?
|
Administration, Intravaginal | 2 | 2018 | 149 | 0.170 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2012 | 2020 | 0.170 |
Why?
|
United States | 15 | 2022 | 72272 | 0.160 |
Why?
|
Societies, Medical | 1 | 2011 | 3900 | 0.160 |
Why?
|
Progestins | 2 | 2018 | 301 | 0.160 |
Why?
|
Embryonic Development | 5 | 2017 | 721 | 0.160 |
Why?
|
Family Planning Services | 1 | 2022 | 266 | 0.160 |
Why?
|
Pregnancy Complications, Neoplastic | 2 | 2017 | 258 | 0.160 |
Why?
|
Ovarian Neoplasms | 2 | 2015 | 4849 | 0.160 |
Why?
|
Logistic Models | 5 | 2018 | 13245 | 0.150 |
Why?
|
Odds Ratio | 5 | 2018 | 9643 | 0.150 |
Why?
|
Reproductive Rights | 1 | 2018 | 31 | 0.150 |
Why?
|
Informed Consent | 1 | 2024 | 1007 | 0.150 |
Why?
|
Luteinizing Hormone | 1 | 2020 | 820 | 0.150 |
Why?
|
Estrogens | 6 | 2001 | 1521 | 0.150 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 1963 | 0.140 |
Why?
|
Intergenerational Relations | 1 | 2017 | 67 | 0.140 |
Why?
|
Gravidity | 1 | 2017 | 50 | 0.140 |
Why?
|
Marital Status | 1 | 2019 | 425 | 0.140 |
Why?
|
Vitrification | 1 | 2017 | 51 | 0.140 |
Why?
|
Single-Blind Method | 2 | 2018 | 1575 | 0.140 |
Why?
|
Menotropins | 1 | 1996 | 41 | 0.140 |
Why?
|
Menstrual Cycle | 2 | 2011 | 539 | 0.140 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2017 | 94 | 0.140 |
Why?
|
Injections, Intramuscular | 3 | 2014 | 555 | 0.140 |
Why?
|
Cohort Studies | 13 | 2022 | 41457 | 0.130 |
Why?
|
Anastomosis, Surgical | 1 | 2020 | 982 | 0.130 |
Why?
|
Case-Control Studies | 9 | 2024 | 22148 | 0.130 |
Why?
|
Testosterone | 3 | 2020 | 2472 | 0.130 |
Why?
|
Biomimetics | 1 | 2017 | 171 | 0.130 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2021 | 3514 | 0.130 |
Why?
|
Down-Regulation | 1 | 2023 | 2915 | 0.130 |
Why?
|
Contraceptive Agents, Female | 1 | 2017 | 118 | 0.130 |
Why?
|
Risk Assessment | 4 | 2024 | 23972 | 0.130 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2017 | 180 | 0.130 |
Why?
|
Bone Marrow Diseases | 1 | 2017 | 233 | 0.120 |
Why?
|
Anemia, Aplastic | 1 | 2017 | 230 | 0.120 |
Why?
|
BRCA1 Protein | 2 | 2022 | 1149 | 0.120 |
Why?
|
Biological Assay | 1 | 2018 | 626 | 0.120 |
Why?
|
Hematologic Neoplasms | 1 | 2007 | 1896 | 0.120 |
Why?
|
Kidney Failure, Chronic | 2 | 1998 | 2477 | 0.120 |
Why?
|
Models, Genetic | 3 | 2001 | 3431 | 0.120 |
Why?
|
Risk Factors | 15 | 2019 | 74115 | 0.120 |
Why?
|
Administration, Cutaneous | 5 | 2000 | 712 | 0.120 |
Why?
|
Prenatal Care | 1 | 2022 | 1140 | 0.120 |
Why?
|
Osteoporosis | 2 | 2001 | 1604 | 0.120 |
Why?
|
Quality Control | 2 | 2015 | 831 | 0.120 |
Why?
|
Climacteric | 1 | 1994 | 57 | 0.120 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1768 | 0.120 |
Why?
|
Ovulation | 2 | 2009 | 181 | 0.120 |
Why?
|
Physician-Patient Relations | 2 | 2014 | 3239 | 0.120 |
Why?
|
Child | 7 | 2024 | 80079 | 0.110 |
Why?
|
Drug Administration Schedule | 3 | 2018 | 4845 | 0.110 |
Why?
|
Religion | 1 | 2017 | 372 | 0.110 |
Why?
|
Gene Frequency | 1 | 2001 | 3601 | 0.110 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1230 | 0.110 |
Why?
|
Cross-Over Studies | 6 | 2000 | 2079 | 0.110 |
Why?
|
Severity of Illness Index | 4 | 2019 | 15828 | 0.110 |
Why?
|
Skinfold Thickness | 1 | 2014 | 163 | 0.110 |
Why?
|
Gestational Age | 2 | 2020 | 3577 | 0.110 |
Why?
|
Cannabis | 1 | 2020 | 441 | 0.110 |
Why?
|
Leiomyoma | 2 | 2001 | 636 | 0.110 |
Why?
|
Family Characteristics | 1 | 2019 | 992 | 0.110 |
Why?
|
Diabetes, Gestational | 1 | 2023 | 1250 | 0.110 |
Why?
|
Lipoproteins | 1 | 1998 | 879 | 0.110 |
Why?
|
Sex Factors | 2 | 2019 | 10548 | 0.110 |
Why?
|
Pregnancy Complications | 2 | 2018 | 2948 | 0.110 |
Why?
|
Health Benefit Plans, Employee | 1 | 2016 | 332 | 0.110 |
Why?
|
Luteal Cells | 1 | 2013 | 19 | 0.110 |
Why?
|
Birth Weight | 2 | 2023 | 2101 | 0.110 |
Why?
|
Living Donors | 1 | 2017 | 641 | 0.110 |
Why?
|
Aged | 13 | 2019 | 169042 | 0.110 |
Why?
|
Hematoma | 1 | 2018 | 762 | 0.110 |
Why?
|
Time Factors | 8 | 2019 | 39913 | 0.100 |
Why?
|
Body Weight | 2 | 2006 | 4614 | 0.100 |
Why?
|
Comparative Genomic Hybridization | 1 | 2014 | 473 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 11736 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2017 | 10754 | 0.100 |
Why?
|
Injections, Subcutaneous | 1 | 2014 | 671 | 0.100 |
Why?
|
Morula | 1 | 2012 | 11 | 0.100 |
Why?
|
Gynecologic Surgical Procedures | 2 | 2015 | 284 | 0.100 |
Why?
|
Body Height | 1 | 1998 | 1565 | 0.100 |
Why?
|
Ovariectomy | 4 | 2007 | 613 | 0.100 |
Why?
|
Statistics, Nonparametric | 4 | 2011 | 2849 | 0.100 |
Why?
|
Achievement | 1 | 2013 | 288 | 0.100 |
Why?
|
Prognosis | 5 | 2020 | 29600 | 0.100 |
Why?
|
Granulosa Cells | 1 | 2012 | 115 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2023 | 1850 | 0.100 |
Why?
|
Health Literacy | 1 | 2017 | 443 | 0.100 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2005 | 3077 | 0.090 |
Why?
|
Prospective Studies | 11 | 2022 | 54360 | 0.090 |
Why?
|
Premature Birth | 1 | 2023 | 1782 | 0.090 |
Why?
|
Abdominal Cavity | 1 | 2011 | 34 | 0.090 |
Why?
|
Overweight | 2 | 2020 | 2417 | 0.090 |
Why?
|
Robotics | 1 | 2018 | 816 | 0.090 |
Why?
|
Stillbirth | 1 | 2014 | 368 | 0.090 |
Why?
|
Probability | 1 | 2016 | 2475 | 0.090 |
Why?
|
Emergencies | 1 | 2017 | 1217 | 0.090 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2014 | 389 | 0.090 |
Why?
|
Tissue and Organ Harvesting | 2 | 2004 | 373 | 0.090 |
Why?
|
Patient Rights | 1 | 2011 | 125 | 0.090 |
Why?
|
Inservice Training | 1 | 2013 | 375 | 0.090 |
Why?
|
Weight Loss | 2 | 2019 | 2682 | 0.090 |
Why?
|
Boston | 4 | 2011 | 9313 | 0.090 |
Why?
|
Medical Records | 2 | 2009 | 1407 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2016 | 2358 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2827 | 0.090 |
Why?
|
Uterine Neoplasms | 2 | 2001 | 1420 | 0.080 |
Why?
|
Health Care Surveys | 1 | 2017 | 2423 | 0.080 |
Why?
|
Decision Making | 2 | 2014 | 3918 | 0.080 |
Why?
|
Incidence | 4 | 2020 | 21337 | 0.080 |
Why?
|
Vagina | 2 | 2011 | 841 | 0.080 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1852 | 0.080 |
Why?
|
Registries | 3 | 2022 | 8207 | 0.080 |
Why?
|
Anxiety | 3 | 2023 | 4570 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2013 | 12043 | 0.080 |
Why?
|
Homeodomain Proteins | 2 | 2009 | 2413 | 0.080 |
Why?
|
Heart Rate, Fetal | 1 | 2009 | 75 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2595 | 0.080 |
Why?
|
Inhibins | 1 | 2009 | 210 | 0.080 |
Why?
|
Treatment Failure | 2 | 2011 | 2635 | 0.080 |
Why?
|
Cell Count | 2 | 2010 | 1835 | 0.080 |
Why?
|
Parity | 1 | 2012 | 924 | 0.080 |
Why?
|
Sex Ratio | 1 | 2008 | 107 | 0.080 |
Why?
|
Cell Division | 5 | 2006 | 4457 | 0.080 |
Why?
|
Biopsy | 3 | 2017 | 6762 | 0.080 |
Why?
|
Analysis of Variance | 3 | 2005 | 6224 | 0.080 |
Why?
|
Bone Density | 1 | 2001 | 3548 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 5491 | 0.070 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 2509 | 0.070 |
Why?
|
Cervix Uteri | 3 | 2004 | 570 | 0.070 |
Why?
|
Regression Analysis | 2 | 2009 | 6338 | 0.070 |
Why?
|
Organ Transplantation | 1 | 2018 | 1157 | 0.070 |
Why?
|
Receptors, Progesterone | 4 | 2012 | 1129 | 0.070 |
Why?
|
Transplantation Conditioning | 2 | 2021 | 1590 | 0.070 |
Why?
|
Fetal Heart | 1 | 2009 | 281 | 0.070 |
Why?
|
Patient Compliance | 1 | 2017 | 2688 | 0.070 |
Why?
|
Folic Acid | 1 | 2014 | 1323 | 0.070 |
Why?
|
Mammary Glands, Human | 1 | 2008 | 202 | 0.070 |
Why?
|
Infertility, Male | 1 | 2010 | 396 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2018 | 5239 | 0.070 |
Why?
|
Family | 1 | 2017 | 3193 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2689 | 0.070 |
Why?
|
Epidermal Growth Factor | 1 | 2009 | 699 | 0.070 |
Why?
|
Gonadal Steroid Hormones | 2 | 2020 | 702 | 0.070 |
Why?
|
Health Policy | 1 | 2018 | 2682 | 0.070 |
Why?
|
Educational Measurement | 1 | 2013 | 1252 | 0.060 |
Why?
|
Fetus | 1 | 2013 | 1862 | 0.060 |
Why?
|
Half-Life | 2 | 1998 | 650 | 0.060 |
Why?
|
Gonadotropins, Pituitary | 1 | 2005 | 69 | 0.060 |
Why?
|
Pedigree | 4 | 2001 | 4539 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2010 | 1697 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2016 | 7798 | 0.060 |
Why?
|
Child of Impaired Parents | 1 | 2008 | 460 | 0.060 |
Why?
|
Radiotherapy | 1 | 2011 | 1497 | 0.060 |
Why?
|
Glioma | 1 | 2020 | 3453 | 0.060 |
Why?
|
HIV Infections | 1 | 2011 | 17337 | 0.060 |
Why?
|
Internet | 1 | 2017 | 3090 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12447 | 0.060 |
Why?
|
Child, Preschool | 3 | 2023 | 42188 | 0.060 |
Why?
|
Pilot Projects | 2 | 2017 | 8618 | 0.060 |
Why?
|
Coercion | 1 | 2024 | 69 | 0.060 |
Why?
|
Fellowships and Scholarships | 1 | 2013 | 1115 | 0.060 |
Why?
|
Bone and Bones | 2 | 2013 | 2565 | 0.060 |
Why?
|
Polymerase Chain Reaction | 5 | 2012 | 6074 | 0.060 |
Why?
|
Animals | 13 | 2023 | 168201 | 0.060 |
Why?
|
Depression | 3 | 2023 | 8132 | 0.050 |
Why?
|
Morphogenesis | 1 | 2007 | 741 | 0.050 |
Why?
|
Health Care Costs | 1 | 2016 | 3238 | 0.050 |
Why?
|
Laparoscopy | 3 | 2011 | 2030 | 0.050 |
Why?
|
Infant | 2 | 2023 | 36152 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2017 | 58894 | 0.050 |
Why?
|
Donor Selection | 1 | 2024 | 232 | 0.050 |
Why?
|
Ultrasonography | 5 | 2013 | 5964 | 0.050 |
Why?
|
Acupuncture Therapy | 1 | 2007 | 486 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2018 | 4488 | 0.050 |
Why?
|
Attitude to Health | 1 | 2011 | 2024 | 0.050 |
Why?
|
Paclitaxel | 1 | 2010 | 1730 | 0.050 |
Why?
|
Sperm Motility | 1 | 2023 | 266 | 0.050 |
Why?
|
Aging | 2 | 2017 | 8699 | 0.050 |
Why?
|
Glomerulonephritis | 1 | 2004 | 331 | 0.050 |
Why?
|
Receptors, Prolactin | 1 | 2001 | 16 | 0.050 |
Why?
|
Data Collection | 1 | 2011 | 3315 | 0.050 |
Why?
|
Croatia | 1 | 2001 | 34 | 0.050 |
Why?
|
Diethylstilbestrol | 1 | 2001 | 87 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2013 | 1921 | 0.050 |
Why?
|
Trust | 1 | 2006 | 528 | 0.050 |
Why?
|
Russia | 2 | 1999 | 382 | 0.050 |
Why?
|
Mullerian Ducts | 1 | 2001 | 203 | 0.050 |
Why?
|
Testis | 1 | 2004 | 792 | 0.040 |
Why?
|
Endometrium | 3 | 2017 | 403 | 0.040 |
Why?
|
Embryonic Stem Cells | 1 | 2008 | 1262 | 0.040 |
Why?
|
Diploidy | 1 | 2000 | 132 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2008 | 1662 | 0.040 |
Why?
|
Th1 Cells | 1 | 2005 | 1027 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15908 | 0.040 |
Why?
|
Pregnancy, High-Risk | 1 | 2000 | 121 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2010 | 2644 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 4935 | 0.040 |
Why?
|
Twins, Monozygotic | 1 | 2001 | 470 | 0.040 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2005 | 550 | 0.040 |
Why?
|
Sperm Count | 1 | 2020 | 229 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2005 | 1550 | 0.040 |
Why?
|
Culture Media | 1 | 2021 | 895 | 0.040 |
Why?
|
Kyrgyzstan | 1 | 1998 | 3 | 0.040 |
Why?
|
Blastomeres | 1 | 1998 | 29 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2009 | 3688 | 0.040 |
Why?
|
Anesthesia, Intravenous | 1 | 2019 | 129 | 0.040 |
Why?
|
Cyclophosphamide | 1 | 2004 | 2218 | 0.040 |
Why?
|
Semen Analysis | 1 | 2020 | 236 | 0.040 |
Why?
|
Lactation Disorders | 1 | 2017 | 14 | 0.040 |
Why?
|
Cicatrix | 1 | 2004 | 785 | 0.040 |
Why?
|
Parthenogenesis | 1 | 2017 | 30 | 0.040 |
Why?
|
BRCA2 Protein | 1 | 2022 | 797 | 0.040 |
Why?
|
Cannabinoids | 1 | 2020 | 172 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 1995 | 6340 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2012 | 15251 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9172 | 0.040 |
Why?
|
Clinical Competence | 1 | 2013 | 4789 | 0.040 |
Why?
|
Genital Diseases, Female | 1 | 1998 | 192 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2009 | 3607 | 0.030 |
Why?
|
Cytokines | 2 | 2018 | 7373 | 0.030 |
Why?
|
Anesthesia, General | 1 | 2004 | 1173 | 0.030 |
Why?
|
Absorption | 1 | 1996 | 242 | 0.030 |
Why?
|
Abortifacient Agents, Nonsteroidal | 1 | 2017 | 64 | 0.030 |
Why?
|
Intraoperative Complications | 2 | 2000 | 1161 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 194 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2017 | 573 | 0.030 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 1998 | 276 | 0.030 |
Why?
|
Pregnancy, Animal | 1 | 1996 | 124 | 0.030 |
Why?
|
Medroxyprogesterone Acetate | 1 | 1996 | 155 | 0.030 |
Why?
|
Israel | 1 | 1998 | 716 | 0.030 |
Why?
|
Suction | 1 | 2017 | 266 | 0.030 |
Why?
|
Mexico | 1 | 1998 | 756 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2780 | 0.030 |
Why?
|
Anesthetics, Intravenous | 1 | 2019 | 394 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 1999 | 733 | 0.030 |
Why?
|
Fentanyl | 1 | 2019 | 433 | 0.030 |
Why?
|
Fetal Death | 1 | 2017 | 435 | 0.030 |
Why?
|
Gene Expression | 3 | 2000 | 7568 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1663 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2007 | 3680 | 0.030 |
Why?
|
Genetic Variation | 2 | 2019 | 6561 | 0.030 |
Why?
|
Ergotamines | 1 | 1994 | 4 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2001 | 7583 | 0.030 |
Why?
|
Belladonna Alkaloids | 1 | 1994 | 4 | 0.030 |
Why?
|
Methysergide | 1 | 1994 | 28 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 10199 | 0.030 |
Why?
|
Panax | 1 | 1994 | 28 | 0.030 |
Why?
|
Catheterization | 1 | 2000 | 1428 | 0.030 |
Why?
|
Comorbidity | 1 | 2009 | 10505 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2009 | 11116 | 0.030 |
Why?
|
Age of Onset | 1 | 2001 | 3302 | 0.030 |
Why?
|
Colorado | 1 | 2014 | 165 | 0.030 |
Why?
|
Reoperation | 1 | 2004 | 4300 | 0.030 |
Why?
|
Double-Blind Method | 3 | 2000 | 12334 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 1995 | 522 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2001 | 939 | 0.030 |
Why?
|
Plants, Medicinal | 1 | 1994 | 165 | 0.030 |
Why?
|
Genotype | 3 | 2008 | 12978 | 0.030 |
Why?
|
Phenobarbital | 1 | 1994 | 191 | 0.030 |
Why?
|
Directive Counseling | 1 | 2015 | 170 | 0.030 |
Why?
|
Mice, Inbred BALB C | 4 | 2007 | 6188 | 0.030 |
Why?
|
Adrenergic alpha-Agonists | 1 | 1994 | 177 | 0.030 |
Why?
|
Serum Albumin | 1 | 1996 | 672 | 0.030 |
Why?
|
Cell Survival | 2 | 2017 | 5780 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2008 | 11874 | 0.030 |
Why?
|
Genetics, Population | 1 | 1998 | 935 | 0.030 |
Why?
|
Cadaver | 1 | 2017 | 1358 | 0.030 |
Why?
|
RNA | 2 | 2017 | 2713 | 0.030 |
Why?
|
Hypertension, Pulmonary | 1 | 2004 | 1580 | 0.030 |
Why?
|
Sexual Partners | 1 | 2018 | 800 | 0.030 |
Why?
|
Propofol | 1 | 2019 | 602 | 0.030 |
Why?
|
Smoking | 2 | 2012 | 9050 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8516 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2001 | 1380 | 0.030 |
Why?
|
Twins | 1 | 1994 | 340 | 0.030 |
Why?
|
Receptors, LH | 1 | 2012 | 18 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2017 | 1185 | 0.030 |
Why?
|
Receptors, Prostaglandin E, EP3 Subtype | 1 | 2012 | 22 | 0.030 |
Why?
|
Telomerase | 1 | 2017 | 744 | 0.030 |
Why?
|
Tissue Banks | 1 | 2013 | 184 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39063 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 1998 | 1810 | 0.020 |
Why?
|
Recurrence | 1 | 2004 | 8426 | 0.020 |
Why?
|
Clone Cells | 1 | 1995 | 1657 | 0.020 |
Why?
|
Genes, BRCA2 | 1 | 2015 | 590 | 0.020 |
Why?
|
Women's Health | 2 | 2014 | 2065 | 0.020 |
Why?
|
Mice | 8 | 2023 | 81368 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2023 | 2896 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2004 | 4174 | 0.020 |
Why?
|
Blood Pressure | 2 | 1999 | 8472 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 7995 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2019 | 2112 | 0.020 |
Why?
|
Genes, BRCA1 | 1 | 2015 | 753 | 0.020 |
Why?
|
Injections | 1 | 1994 | 832 | 0.020 |
Why?
|
Cricetulus | 1 | 2012 | 814 | 0.020 |
Why?
|
Placebos | 1 | 1995 | 1667 | 0.020 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2011 | 115 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1496 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2001 | 2637 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 12966 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2000 | 2187 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 876 | 0.020 |
Why?
|
RNA, Messenger | 4 | 2001 | 12758 | 0.020 |
Why?
|
Random Allocation | 1 | 1995 | 2392 | 0.020 |
Why?
|
CHO Cells | 1 | 2012 | 1387 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 17878 | 0.020 |
Why?
|
Fragile X Syndrome | 1 | 2011 | 116 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9586 | 0.020 |
Why?
|
Glycosylation | 1 | 2012 | 1098 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1884 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2011 | 783 | 0.020 |
Why?
|
Siblings | 1 | 2013 | 824 | 0.020 |
Why?
|
Cricetinae | 1 | 2012 | 2424 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2010 | 403 | 0.020 |
Why?
|
Research Design | 2 | 2020 | 6174 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2012 | 748 | 0.020 |
Why?
|
Renal Dialysis | 1 | 1998 | 1799 | 0.020 |
Why?
|
Postoperative Complications | 3 | 2019 | 15612 | 0.020 |
Why?
|
Menarche | 1 | 2012 | 532 | 0.020 |
Why?
|
Cell Size | 1 | 2010 | 624 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2015 | 1110 | 0.020 |
Why?
|
Milk, Human | 1 | 2012 | 486 | 0.020 |
Why?
|
Drug Combinations | 1 | 1994 | 2048 | 0.020 |
Why?
|
Motivation | 1 | 2017 | 2003 | 0.020 |
Why?
|
Organ Culture Techniques | 2 | 2000 | 794 | 0.020 |
Why?
|
DNA Damage | 1 | 2017 | 2446 | 0.020 |
Why?
|
Abortion, Induced | 1 | 2013 | 461 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1995 | 6126 | 0.020 |
Why?
|
Kinetics | 1 | 1995 | 6370 | 0.020 |
Why?
|
Anthropometry | 1 | 2012 | 1338 | 0.020 |
Why?
|
Electroacupuncture | 1 | 2007 | 66 | 0.020 |
Why?
|
Androgens | 1 | 1994 | 1285 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2009 | 535 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2012 | 1034 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2010 | 0.020 |
Why?
|
Mesoderm | 1 | 2009 | 674 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2017 | 2768 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2012 | 10432 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5034 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2007 | 347 | 0.020 |
Why?
|
Peer Review | 1 | 2007 | 217 | 0.020 |
Why?
|
In Situ Hybridization | 2 | 2000 | 1900 | 0.010 |
Why?
|
DNA Primers | 1 | 2009 | 2817 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2012 | 16967 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2315 | 0.010 |
Why?
|
Cell Cycle | 1 | 2012 | 2930 | 0.010 |
Why?
|
Epithelial Cells | 2 | 2009 | 3672 | 0.010 |
Why?
|
Stromal Cells | 2 | 2001 | 1329 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3605 | 0.010 |
Why?
|
Infusion Pumps | 1 | 2004 | 163 | 0.010 |
Why?
|
Ovum | 1 | 2004 | 187 | 0.010 |
Why?
|
Health Surveys | 1 | 2013 | 4037 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2010 | 18937 | 0.010 |
Why?
|
Epoprostenol | 1 | 2004 | 247 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14648 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2004 | 472 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2007 | 1380 | 0.010 |
Why?
|
Fetal Growth Retardation | 1 | 2006 | 580 | 0.010 |
Why?
|
Models, Statistical | 1 | 2016 | 5073 | 0.010 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2009 | 1084 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3723 | 0.010 |
Why?
|
Calcium | 1 | 1995 | 5717 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2014 | 3411 | 0.010 |
Why?
|
Transfection | 1 | 2009 | 5766 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2756 | 0.010 |
Why?
|
Infant, Low Birth Weight | 1 | 2006 | 869 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 3593 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8833 | 0.010 |
Why?
|
Biomedical Research | 1 | 2016 | 3426 | 0.010 |
Why?
|
Gels | 1 | 2001 | 420 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9345 | 0.010 |
Why?
|
Clomiphene | 1 | 2000 | 71 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 4117 | 0.010 |
Why?
|
Life Style | 1 | 2012 | 3904 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3419 | 0.010 |
Why?
|
Turkmenistan | 1 | 1999 | 3 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2048 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12661 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2009 | 2425 | 0.010 |
Why?
|
Computational Biology | 1 | 2012 | 3509 | 0.010 |
Why?
|
Hypertension | 1 | 1999 | 8529 | 0.010 |
Why?
|
Survival Rate | 1 | 2013 | 12719 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2871 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22115 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1999 | 861 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36402 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 30016 | 0.010 |
Why?
|
Base Sequence | 1 | 2009 | 12421 | 0.010 |
Why?
|
Fibroblasts | 1 | 2008 | 4137 | 0.010 |
Why?
|
Quantitative Trait, Heritable | 1 | 2000 | 540 | 0.010 |
Why?
|
Exercise | 1 | 1994 | 5886 | 0.010 |
Why?
|
Drug Synergism | 1 | 2001 | 1755 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2008 | 11514 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 2000 | 1096 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1996 | 225 | 0.010 |
Why?
|
Diet | 1 | 2014 | 8048 | 0.010 |
Why?
|
Likelihood Functions | 1 | 1999 | 991 | 0.010 |
Why?
|
Laparotomy | 1 | 1998 | 456 | 0.010 |
Why?
|
Epithelium | 1 | 2000 | 1603 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15576 | 0.010 |
Why?
|
Signal Transduction | 2 | 2009 | 23416 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7847 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2004 | 2016 | 0.010 |
Why?
|
Prevalence | 1 | 2011 | 15689 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20556 | 0.010 |
Why?
|
Proteins | 1 | 2008 | 6030 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 1998 | 15498 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9417 | 0.010 |
Why?
|
Phenotype | 1 | 2008 | 16571 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2000 | 6305 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2001 | 3608 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2001 | 3309 | 0.010 |
Why?
|
Reference Values | 1 | 1995 | 4919 | 0.000 |
Why?
|
Mental Health | 1 | 2000 | 3251 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1996 | 8166 | 0.000 |
Why?
|
DNA | 1 | 1999 | 7196 | 0.000 |
Why?
|
Quality of Life | 1 | 2007 | 13347 | 0.000 |
Why?
|
Thyroid (USP) | 1 | 1962 | 3 | 0.000 |
Why?
|
Rats | 1 | 1996 | 23717 | 0.000 |
Why?
|
Thyroid Hormones | 1 | 1962 | 403 | 0.000 |
Why?
|
Hospitalization | 1 | 1998 | 10704 | 0.000 |
Why?
|
Thyroid Gland | 1 | 1962 | 1170 | 0.000 |
Why?
|